Literature DB >> 15304599

Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study.

G-J de Haan1, P Edelbroek, J Segers, M Engelsman, D Lindhout, M Dévilé-Notschaele, P Augustijn.   

Abstract

The authors describe 12 pregnancies in women with epilepsy using lamotrigine (LTG) monotherapy. A seizure increase in nine pregnancies was probably related to a gradual decline of LTG level-to-dose ratio to 40% of baseline. After delivery, LTG kinetics returned swiftly to baseline, causing toxic side effects in some women. Frequent LTG level monitoring and appropriate dose adjustments are advised in the period before and during pregnancy and after delivery, especially in women on LTG monotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304599     DOI: 10.1212/01.wnl.0000133213.10244.fd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  43 in total

Review 1.  Management of focal-onset seizures: an update on drug treatment.

Authors:  Svein I Johannessen; Elinor Ben-Menachem
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  The importance of increased clearance of lamotrigine during pregnancy.

Authors:  Elinor Ben-Menachem
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

3.  EURAP outcomes for seizure control during pregnancy: useful and encouraging data.

Authors:  Page B Pennell
Journal:  Epilepsy Curr       Date:  2006 Nov-Dec       Impact factor: 7.500

Review 4.  Epilepsy in pregnancy.

Authors:  Torbjörn Tomson; Vilho Hiilesmaa
Journal:  BMJ       Date:  2007-10-13

5.  Hormones, seizures, and lamotrigine: Oh, my!

Authors:  Page B Pennell
Journal:  Epilepsy Curr       Date:  2008 Jan-Feb       Impact factor: 7.500

6.  Some long awaited answers regarding seizures during pregnancy.

Authors:  Elinor Ben-Menachem
Journal:  Epilepsy Curr       Date:  2009 Jan-Feb       Impact factor: 7.500

7.  Does increased levetiracetam clearance during pregnancy require planned intervention?

Authors:  Bassel W Abou-Khalil
Journal:  Epilepsy Curr       Date:  2008 May-Jun       Impact factor: 7.500

Review 8.  Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.

Authors:  Kristina M Deligiannidis; Nancy Byatt; Marlene P Freeman
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

Review 9.  Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Authors:  John J Craig
Journal:  Obstet Med       Date:  2012-02-20

10.  [Pregnancy and epilepsy. Retrospective analysis of 118 patients].

Authors:  J Rück; J Bauer
Journal:  Nervenarzt       Date:  2008-06       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.